Membranous Nephropathy (MN): Baseline Health Related Quality of Life (HRQOL) in Patients with Severe Nephrotic Syndrome (SNS) in the Membranous Nephropathy Trial of Rituximab (MENTOR) RCT

Category Primary study
JournalJournal of the American Society of Nephrology
Year 2016
This article has no abstract
Epistemonikos ID: 6f44252f1aca871adf3e750d1f4abf59c1ed8a9e
First added on: Feb 15, 2025